Retina Macula Institute of Arizona is a clinical research site located in Scottsdale, Arizona, United States 85255.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Retina Macula Institute of Arizona has participated in 11 clinical trials with 10 currently active.
Therapeutic areas: Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration (AMD), Geographic Atrophy (GA).
Sponsors: Ocular Therapeutix, Inc., Regeneron Pharmaceuticals, Boehringer Ingelheim.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Retina Macula Institute of Arizona has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Retina Macula Institute of Arizona has 11 clinical trials on record, with 10 currently active. Their work covers Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration (AMD), Geographic Atrophy (GA).
Yes — Retina Macula Institute of Arizona holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.